Altamira Therapeutics Ltd. Other Finance Income
Altamira Therapeutics Ltd. (CYTOF) reported Other Finance Income of $1.66 million for the 6-month period ending 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Income Statement › Other Income
ifrs-full:OtherFinanceIncome · last filed 2025-08-29
CHF
| Period end | Other Finance Income 6 month | Other Finance Income 12 month |
|---|---|---|
| 2023-12-31 | 354.09K CHF 20-F/A · filed 2024-04-22 | |
| 2023-06-30 | 37.02K CHF 6-K · filed 2023-09-12 | |
| 2022-12-31 | 565.40K CHF 20-F/A · filed 2024-04-22 | |
| 2022-06-30 | 509.14K CHF 6-K · filed 2023-09-12 | |
| 2021-12-31 | 79.24K CHF 20-F/A · filed 2024-04-22 |
USD
| Period end | Other Finance Income 6 month | Other Finance Income 12 month |
|---|---|---|
| 2025-06-30 | $1.66M 6-K · filed 2025-08-29 | |
| 2024-12-31 | $3.33K 20-F · filed 2025-04-30 | |
| 2024-06-30 | $513.00 6-K · filed 2025-08-29 | |
| 2023-12-31 | $394.09K 20-F · filed 2025-04-30 | |
| 2023-06-30 | $69.54K 6-K · filed 2024-09-24 | |
| 2022-12-31 | $592.04K 20-F · filed 2025-04-30 |